Sex differences in cardiovascular mortality in diabetics and nondiabetic subjects: A population-based study (Italy)

International Journal of Endocrinology

Volumn 2015, Issue , 2015, Pages

  Ballotari, Paola ^a,b   Ranieri, Sofia Chiatamone ^b   Luberto, Ferdinando ^a,b   Caroli, Stefania ^a,b   Greci, Marina ^a   Giorgi Rossi, Paolo ^a,b   Manicardi, Valeria ^c  

^a PATHOLOGY UNIT   (Italy)

^b S MARIA NUOVA HOSPITAL   (Italy)

^c Ospedale di Montecchio   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE REGISTRY; FEMALE; FOLLOW UP; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; INCIDENCE; ITALY; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 84926645664     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2015/914057     Document Type: Article

References (71)

1. International Diabetes Federation, IDF Diabetes Atlas, International Diabetes Federation, Brussels, Belgium, 6th edition, 2013.
2. ISTAT, "Indagine Multiscopo 'Aspetti della vita quotidiana'", in Anno 2011, ISTAT, Rome, Italy, 2012.
3. WHO, "World Health Organisation Study Group on Diabetes Mellitus", Tech. Rep. 727, WHO, Geneva, Switzerland, 1985.
4. R. J. Jarrett, "Diabetes, hyperglycaemia and arterial disease", in Complications of Diabetes, H. Keen and R. J. Jarrett, Eds., pp. 179-203, Edward Arnold, London, UK, 2nd edition, 1982.
5. G. L. Booth, M. K. Kapral, K. Fung, and J. V. Tu, "Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study", The Lancet, vol. 368, no. 9529, pp. 29-36, 2006.
6. S. R. Preis, S.-J. Hwang, S. Coady et al., "Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the framingham heart study, 1950 to 2005", Circulation, vol. 119, no. 13, pp. 1728-1735, 2009.
7. T. Almdal, H. Scharling, J. S. Jensen, and H. Vestergaard, "The independent effect of type 2 diabetesmellitus on ischemic heart disease, stroke, and death: a population-based study of 13, 000 men and womenwith 20 years of follow-up", Archives of Internal Medicine, vol. 164, no. 13, pp. 1422-1426, 2004.
8. K. N. Barnett, S. A. Ogston, M. E. T. McMurdo, A. D. Morris, and J. M. M. Evans, "A 12-year follow-up study of all-cause and cardiovascular mortality among 10 532 people newly diagnosed with Type 2 diabetes in Tayside, Scotland", Diabetic Medicine, vol. 27, no. 10, pp. 1124-1129, 2010.
9. N. Sarwar, P. Gao, S. R. Seshasai, R. Gobin, S. Kaptoge, and The Emerging Risk Factors Collaboration, "Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies", The Lancet, vol. 375, pp. 2215-2222, 2010.
10. S. Vilbergsson, S. Vilbergsson, G. Sigurdsson, G. Sigurdsson, H. Sigvaldason, and N. Sigfusson, "Coronary heart disease mortality amongst non-insulin-dependent diabetic subjects in Iceland: the independent effect of diabetes. The Reykjavik Study 17-year follow up", Journal of Internal Medicine, vol. 244, no. 4, pp. 309-316, 1998.
11. W. J. Butler, L. D. Ostrander Jr., W. J. Carman, and D. E. Lamphiear, "Mortality from coronary heart disease in the tecumseh study. Long-term effect of diabetes mellitus, glucose tolerance and other risk factors", The American Journal of Epidemiology, vol. 121, no. 4, pp. 541-547, 1985.
12. J. C. Kleinman, R. P. Donahue, M. I. Harris, F. F. Finucane, J. H. Madans, and D. B. Brock, "Mortality among diabetics in a national sample", The American Journal of Epidemiology, vol. 128, no. 2, pp. 389-401, 1988.
13. G.-M. Lin, Y.-H. Li, C.-L. Lin, J.-H. Wang, and C.-L. Han, "Gender differences in the impact of diabetes on mortality in patients with established coronary artery disease: a report from the eastern Taiwan integrated health care delivery system of Coronary Heart Disease (ET-CHD) registry, 1997-2006", Journal of Cardiology, vol. 61, no. 6, pp. 393-398, 2013.
14. A. M. Kanaya, D. Grady, and E. Barrett-Connor, "Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetesmellitus: ameta-analysis", Archives of Internal Medicine, vol. 162, no. 15, pp. 1737-1745, 2002.
15. B. V. Howard, L. D. Cowan, O. Go, T. K. Welty, D. C. Robbins, and E. T. Lee, "Adverse effects of diabetes on multiple cardiovascular disease risk factors in women: the strong heart study", Diabetes Care, vol. 21, no. 8, pp. 1258-1265, 1998.
16. A. Becker, G. Bos, F. De Vegt et al., "Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease:10-Year followup of the Hoorn study", European Heart Journal, vol. 24, no. 15, pp. 1406-1413, 2003.
17. A. Juutilainen, S. Kortelainen, S. Lehto, T. Rönnemaa, K. Pyörälä, and M. Laakso, "Gender difference in the impact of type 2 diabetes on coronary heart disease risk", Diabetes Care, vol. 27, no. 12, pp. 2898-2904, 2004.
18. M. M. Roche and P. P. Wang, "Sex differences in all-cause and cardiovascular mortality, hospitalization for individuals with and without diabetes, and patients with diabetes diagnosed early and late", Diabetes Care, vol. 36, no. 9, pp. 2582-2590, 2013.
19. E. Barrett-Connor, E.-G. V. Giardina, A. K. Gitt, U. Gudat, H. O. Steinberg, and D. Tschoepe, "Women and heart disease: the role of diabetes and hyperglycemia", Archives of Internal Medicine, vol. 164, no. 9, pp. 934-942, 2004.
20. W. B. Kannel, "The Framingham Study: Historical insight on the impact of cardiovascular risk factors inmen versus women", Journal of Gender-Specific Medicine, vol. 5, no. 2, pp. 27-37, 2002.
21. E. L. Barrett-Connor, B. A. Cohn, D. L. Wingard, and S. L. Edelstein, "Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than inmen?The Rancho Bernardo Study", Journal of the American Medical Association, vol. 265, no. 5, pp. 627-631, 1991.
22. W. L. Lee, A. M. Cheung, D. Cape, and B. Zinman, "Impact of diabetes on coronary artery disease in women andmen: a metaanalysis of prospective studies", Diabetes Care, vol. 23, no. 7, pp. 962-968, 2000.
23. R. Huxley, F. Barzi, and M. Woodward, "Adverse effects of diabetes on multiple cardiovascular disease risk factors in women: the strong heart study", British Medical Journal, vol. 332, no. 7533, pp. 73-76, 2006.
24. P. Ballotari, S. Chiatamone Ranieri, M. Vicentini et al., "Building a population-based diabetes register: an Italian experience", Diabetes Research and Clinical Practice, vol. 103, no. 1, pp. 79-87, 2014.
25. R. Gnavi, R. Picariello, L. La Karaghiosoff, G. Costa, and C. Giorda, "Determinants of quality in diabetes care process: the population-based Torino study", Diabetes Care, vol. 32, no. 11, pp. 1986-1992, 2009.
26. ISTAT, Resident population on December 31st, 2012, http://www.demo.istat.it/bil2012/index.html.
27. N. Sarwar, P. Gao, and S. R. Seshasai, "Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies", The Lancet, vol. 375, no. 9733, pp. 2215-2222, 2010.
28. T. K. Schramm, G. H. Gislason, L. Køber et al., "Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people", Circulation, vol. 117, no. 15, pp. 1945-1954, 2008.
29. K. S. Taylor, C. J. Heneghan, A. J. Farmer et al., "All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U. K. primary care database", Diabetes Care, vol. 36, no. 8, pp. 2366-2371, 2013.
30. E. W. Gregg, Q. Gu, Y. J. Cheng, K. M. V. Narayan, and C. C. Cowie, "Mortality trends in men and women with diabetes, 1971 to 2000", Annals of Internal Medicine, vol. 147, no. 3, pp. 149-155, 2007.
31. H. H. Newnham and J. Silberberg, "Coronary heart disease. Women's hearts are hard to break", The Lancet, vol. 349, pp. S13-S16, 1997.
32. C. E. Walden, R. H. Knopp, P. W. Wahl, K. W. Beach, and E. Strandness Jr., "Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations", The New England Journal of Medicine, vol. 311, no. 15, pp. 953-959, 1984.
33. R. D. Siegel, A. Cupples, E. J. Schaefer, and P. W. F. Wilson, "Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study", Metabolism, vol. 45, no. 10, pp. 1267-1272, 1996.
34. G. Penno, A. Solini, E. Bonora et al., "Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study", Journal of Internal Medicine, vol. 274, no. 2, pp. 176-191, 2013.
35. M. C. Rossi, M. R. Cristofaro, S. Gentile et al., "Sex disparities in the quality of diabetes care: biological and cultural factors may play a different role for different outcomes: a cross-sectional observational study from the amd annals initiative", Diabetes Care, vol. 36, no. 10, pp. 3162-3168, 2013.
36. M. J. Legato, A. Gelzer, R. Goland et al., "Gender-specific care of the patient with diabetes: review and recommendations", Gender Medicine, vol. 3, no. 2, pp. 131-158, 2006.
37. J. Dallongevillle, D. De Bacquer, J. Heidrich et al., "Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event", Heart, vol. 96, no. 21, pp. 1744-1749, 2010.
38. V. G. Vimalananda, D. R. Miller, M. Palnati, C. L. Christiansen, and B. G. Fincke, "Gender disparities in lipid-lowering therapy among veterans with diabetes", Womens Health Issues, vol. 21, no. 4 supplement, pp. S176-S181, 2011.
39. C. Kim, E. A. Kerr, S. J. Bernstein, and S. L. Krein, "Gender disparities in lipid management: the presence of disparities depends on the qualitymeasure", American Journal of Managed Care, vol. 12, no. 3, pp. 133-136, 2006.
40. A. Festa, R. D'Agostino Jr., R. P. Tracy, and S. M. Haffner, "Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study", Diabetes, vol. 51, no. 4, pp. 1131-1137, 2002.
41. L. H. Kuller, R. P. Tracy, J. Shaten, and E. N. Meilahn, "Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study", American Journal of Epidemiology, vol. 144, no. 6, pp. 537-547, 1996.
42. J. B. Meigs, F. B. Hu, N. Rifai, and J. E. Manson, "Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus", Journal of the American Medical Association, vol. 291, no. 16, pp. 1978-1986, 2004.
43. P. M. Ridker, M. Cushman, M. J. Stampfer, R. P. Tracy, and C. H. Hennekens, "Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men", The New England Journal of Medicine, vol. 336, no. 14, pp. 973-979, 1997.
44. M. I. Schmidt, B. B. Duncan, A. R. Sharrett et al., "Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study", The Lancet, vol. 353, no. 9165, pp. 1649-1652, 1999.
45. H. O. Steinberg, G. Paradisi, J. Cronin et al., "Type II diabetes abrogates sex differences in endothelial function in premenopausal women", Circulation, vol. 101, no. 17, pp. 2040-2046, 2000.
46. F. Franconi, I. Campesi, S. Occhioni, and G. Tonolo, "Sexgender differences in diabetes vascular complications and treatment", Endocrine, Metabolic and Immune Disorders-Drug Targets, vol. 12, no. 2, pp. 179-196, 2012.
47. R. P. Donahue, K. Rejman, L. B. Rafalson, J. Dmochowski, S. Stranges, and M. Trevisan, "Sex differences in endothelial function markers before conversion to pre-diabetes: does the clock start ticking earlier among women? The Western New York Study", Diabetes Care, vol. 30, no. 2, pp. 354-359, 2007.
48. M. E. Miller, D. E. Bonds, H. C. Gerstein et al., "The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study", BMJ, vol. 340, no. 7738, Article IDb5444, p. 138, 2010.
49. R. R. Kalyani, M. Lazo, P. Ouyang et al., "Sex differences in diabetes and risk of incident coronary artery disease in healthy young and middle-aged adults", Diabetes Care, vol. 37, no. 3, pp. 830-838, 2014.
50. A. Ferrara, C. M. Mangione, C. Kim et al., "Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes", Diabetes Care, vol. 31, no. 1, pp. 69-74, 2008.
51. D. J. Wexler, R. W. Grant, J. B. Meigs, D. M. Nathan, and E. Cagliero, "Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes", Diabetes Care, vol. 28, no. 3, pp. 514-520, 2005.
52. R. Bugiardini, A. T. Yan, R. T. Yan et al., "Factors influencing underutilization of evidence-based therapies in women", European Heart Journal, vol. 32, no. 11, pp. 1337-1344, 2011.
53. S. Poon, S. G. Goodman, R. T. Yan et al., "Bridging the gender gap: insights from a contemporary analysis of sexrelated differences in the treatment and outcomes of patients with acute coronary syndromes", American Heart Journal, vol. 163, no. 1, pp. 66-73, 2012.
54. S. H. Saydah, J. Fradkin, and C. C. Cowie, "Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes", The Journal of the American Medical Association, vol. 291, no. 3, pp. 335-342, 2004.
55. J. L. Jarvie and J. M. Foody, "Recognizing and improving health care disparities in the prevention of cardiovascular disease in women", Current Cardiology Reports, vol. 12, no. 6, pp. 488-496, 2010.
56. C. Giorda, R. Picariello, E. Nada et al., "The impact of adherence to screening guidelines and of diabetes clinics referral on morbidity and mortality in diabetes", PLoS ONE, vol. 7, no. 4, Article ID e33839, 2012.
57. J. P. Garg and G. L. Bakris, "Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease", Vascular Medicine, vol. 7, no. 1, pp. 35-43, 2002.
58. K. Klausen, K. Borch-Johnsen, B. Feldt-Rasmussen et al., "Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes", Circulation, vol. 110, no. 1, pp. 32-35, 2004.
59. G. T. Russo, A. Giandalia, E. L. Romeo et al., "Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease", Journal of Endocrinological Investigation, vol. 37, no. 3, pp. 261-268, 2014.
60. N. A. Roper, R. W. Bilous, W. F. Kelly, N. C. Unwin, and V. M. Connolly, "Cause-specific mortality in a population with diabetes: South tees diabetes mortality study", Diabetes Care, vol. 25, no. 1, pp. 43-48, 2002.
61. S. L. Seliger, C. Davis, and C. Stehman-Breen, "Gender and the progression of renal disease", Current Opinion in Nephrology and Hypertension, vol. 10, no. 2, pp. 219-225, 2001.
62. S. R. Silbiger and J. Neugarten, "The role of gender in the progression of renal disease", Advances in Renal Replacement Therapy, vol. 10, no. 1, pp. 3-14, 2003.
63. C. J. Schultz, T. Konopelska-Bahu, R. N. Dalton et al., "Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study", Diabetes Care, vol. 22, no. 3, pp. 495-502, 1999.
64. R. Garza, R. Medina, S. Basu, and J. A. Pugh, "Predictors of the rate of renal function decline in non-insulin-dependent diabetes mellitus", American Journal of Nephrology, vol. 17, no. 1, pp. 59-67, 1997.
65. P. Jacobsen, K. Rossing, L. Tarnow et al., "Progressionof diabetic nephropathy in normotensive type 1 diabetic patients", Kidney International, Supplement, vol. 56, no. 71, pp. S101-S105, 1999.
66. M. I. Harris, K. M. Flegal, C. C. Cowie et al., "Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U. S. adults: the Third National Health and Nutrition Examination Survey, 1988-1994", Diabetes Care, vol. 21, no. 4, pp. 518-524, 1998.
67. H. E. Resnick and B. V. Howard, "Diabetes and cardiovascular disease", Annual Review of Medicine, vol. 53, pp. 245-267, 2002.
68. C. Maric, "Sex, diabetes and the kidney", American Journal of Physiology-Renal Physiology, vol. 296, no. 4, pp. F680-F688, 2009.
69. A. Ceriello, S. De Cosmo, S. Gentile et al., Le Monografie Degli Annali AMD 2011 Focus Su: Pattern Assistenziali in Relazione al Livello di Funzionalità Renale, 2012.
70. A. Solini, G. Penno, E. Bonora et al., "Diverging association of reduced glomerular filtration rate and albuminuria with coronary and noncoronary events in patients with type 2 diabetes: The renal insufficiency and cardiovascular events (RIACE) Italian multicenter study", Diabetes Care, vol. 35, no. 1, pp. 143-149, 2012.
71. M. L. Muiesan, E. Ambrosioni, F. V. Costa et al., "Sex differences in hypertension-related renal and cardiovascular diseases in Italy: the I-DEMAND study", Journal of Hypertension, vol. 30, no. 12, pp. 2378-2386, 2012.